- Home
- JRSH vs ESLA Comparison
JRSH vs ESLA Comparison
Compare JRSH & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- ESLA
- Stock Information
- Founded
- JRSH 2016
- ESLA 2021
- Country
- JRSH United States
- ESLA United States
- Employees
- JRSH N/A
- ESLA N/A
- Industry
- JRSH Apparel
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JRSH Consumer Discretionary
- ESLA Health Care
- Exchange
- JRSH Nasdaq
- ESLA Nasdaq
- Market Cap
- JRSH 36.5M
- ESLA 41.6M
- IPO Year
- JRSH 2018
- ESLA N/A
- Fundamental
- Price
- JRSH $3.30
- ESLA $0.89
- Analyst Decision
- JRSH
- ESLA
- Analyst Count
- JRSH 0
- ESLA 0
- Target Price
- JRSH N/A
- ESLA N/A
- AVG Volume (30 Days)
- JRSH 13.9K
- ESLA 15.2K
- Earning Date
- JRSH 11-12-2024
- ESLA 11-26-2024
- Dividend Yield
- JRSH 6.06%
- ESLA N/A
- EPS Growth
- JRSH N/A
- ESLA N/A
- EPS
- JRSH N/A
- ESLA N/A
- Revenue
- JRSH $130,270,418.00
- ESLA N/A
- Revenue This Year
- JRSH $23.86
- ESLA N/A
- Revenue Next Year
- JRSH $10.89
- ESLA N/A
- P/E Ratio
- JRSH N/A
- ESLA N/A
- Revenue Growth
- JRSH N/A
- ESLA N/A
- 52 Week Low
- JRSH $2.68
- ESLA $0.63
- 52 Week High
- JRSH $3.46
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- JRSH 71.44
- ESLA 52.77
- Support Level
- JRSH $2.93
- ESLA $0.74
- Resistance Level
- JRSH $3.46
- ESLA $0.93
- Average True Range (ATR)
- JRSH 0.12
- ESLA 0.12
- MACD
- JRSH 0.03
- ESLA 0.02
- Stochastic Oscillator
- JRSH 71.05
- ESLA 81.25
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.